Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.479, 2005-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Simvastatin reduces cardiovascular risk
Inpharma, Vol. 1, Iss. 1346, 2002-01 ,pp. :
Access to resources
Recommend
Moxifloxacin tops in CAP regardless of resistance level
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 490, 2005-01 ,pp. :
Antihypertensives reduce CV event risk regardless of age
Inpharma, Vol. 1, Iss. 1640, 2008-01 ,pp. :
Risk factors for Rhabdomyolysis with Simvastatin and Atorvastatin
By Golomb Beatrice Evans Marcella
Drug Safety, Vol. 29, Iss. 12, 2006-01 ,pp. :
Risk Factors for Rhabdomyolysis with Simvastatin and Atorvastatin
Drug Safety, Vol. 29, Iss. 11, 2006-01 ,pp. :